Conference abstract · 15 Oct 2013
Conference abstractPublished 15 Oct 2013
Novel structural elements for drug discovery: Identification, synthesis and application
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
It is now commonly accepted that structural diversity of the known drugs is very low. Moreover, it is believed to be one of the reasons, why it is getting more and more difficult to launch the principally novel drugs in the recent years. In the contemporary paradigm of drug discovery under the pressure of shortening turnaround time in lead optimization projects, medicinal chemists are to use only commercially available building blocks that can quickly be delivered. Under these circumstances even the most conceptually attractive compounds have low chances to find the true practical application if they are not commercialized. For example, being highly accessible conventional laboratory reagents pyrrolidine, piperidine and morpholine, left their deep footprint in drug discovery. These are the most frequently reported secondary amines in medicinal chemistry. We wanted to upgrade this toolkit of primitive cyclic amines. Therefore, we identified and synthesized other family members allowing for a variety of forms.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 24 Jun 2019
Plants as an important source of enormous novel chemical structures for drug discovery
Research article · 31 Aug 2015
Synthesis, identification, structural, studies and biological activity of some transition metal complexes with novel heterocyclic azo-schiff base ligand derived from benzimidazole
Conference abstract · 5 Dec 2016
Synthesis of novel anthraquinone anti-cancer drugs: molecular structure, molecular chemical reactivity descriptors and their interactions with DNA
Conference abstract · 18 Oct 2017
Identification of phenanthridinone based inhibitors of BRD2-BD2 bromodomain by structure-based drug discovery approach
More from this journal
The newest in Medicinal Chemistry.
Brief report · 30 Jun 2026
Covalent Drugs in Medicinal Chemistry: Emerging Opportunities and Ongoing Challenges
Commentary · 29 Dec 2025
Accelerating Drug Discovery: Molecular Docking and Virtual Screening
Opinion · 29 Dec 2025
Pharmacophore Modeling: A Cornerstone of Drug Discovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Pavel Mykhailiuk”

